tm logo
ONESOURCE
REGISTERED

on 24 Nov 2021

Last Applicant/ Owned by

PERKINELMER U.S. LLC

710 Bridgeport AveShelton, CT 06484

US

Serial Number

1909962 filed on 17th Jul 2018

Registration Number

TMA1114734 registered on 24th Nov 2021

Registration expiry Date

24th Nov 2031

Correspondent Address

(RIEL PROFESSIONAL CORPORATION)411 Roosevelt Avenue, Suite 206Ottawa

ONTARIO

CA

K2A3X9

ONESOURCE

Trademark usage description

relocation services for businesses, namely, laboratories; relocation services for scientific, pharmaceutical, and medical research, analytical, and di Read More

Classification Information


Class [035]
Relocation services for businesses, namely, laboratories; relocation services for scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories, namely, pre-move testing of equipment, inventory recordation, equipment labeling, dismantling, and packing, handling of specimens, chemicals, and samples, transportation logistics, laboratory set up, unpacking, and post-move laboratory equipment testing and calibration; consulting services, namely, application efficiency and method consulting and design for scientific research and medical analytical and diagnostic laboratories in the nature of identification of customer objectives and goals and providing strategic recommendations; consulting services, namely, research, analysis, and reporting in the field of workflow, productivity analysis, and personnel management in scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories; consulting services, namely, automation, and data services in the nature of business organization and management consulting; consulting services, namely, providing business information and business management advice to others for maintaining, optimizing, and extending the lifecycle and productivity of analytical and diagnostic laboratory equipment; consulting services in the field of purchases, namely, assisting laboratories with the purchase of scientific, pharmaceutical, and medical research, analytical, and diagnostic instruments; consulting services in the field of science and technology, namely, assisting laboratories with identifying scientific, pharmaceutical, and medical research, analytical, and diagnostic instruments for purchase; employment staffing services, namely, filling the temporary staffing needs of scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories


Classification kind code

11

Class [037]
Installation, maintenance, optimization, repair, and refurbishment of laboratory instruments for scientific, pharmaceutical, and medical research, analysis, and diagnostic use; Installation, maintenance, optimization, repair, and refurbishment of computer hardware for scientific, medical, and pharmaceutical research, analysis, and diagnostics use


Classification kind code

11

Class [041]
Training services, namely, training advisory and consultancy services relating to the use, handling, optimization, calibration, and maintenance of laboratory equipment and related software; educational services, namely, conducting technical discussion meetings and technical training seminars on topics of business, administration operation, regulatory and standards compliance, and management of scientific, pharmaceutical, and medical research, analytical and diagnostic laboratories, experimental testing and analysis, data management, and quality assurance


Classification kind code

11

Class [042]
Information services, namely information integrity governance, information management, information reporting, information monitoring, information translation, information transformation, information storage, information analytics, and information integration in the field of information generated in scientific, pharmaceutical, and medical research, analytical and diagnostic laboratories; computer support services for laboratories, namely, providing information technical support performed by science-knowledgeable professionals, and electronic monitoring of data; information technology support services in the nature of asset management and risk mitigation, namely, reporting on instrument service histories, utilization of the assets, end of product life information and product replacement costs all related to scientific, laboratory medical diagnostic, and biomedical equipment; Information technology services in the nature of planning, designing, implementing, deploying, installing, customizing, integrating, managing, migrating, testing, validating, and supporting of computer software, computer hardware and laboratory equipment within the field of laboratory science; analytics services in the nature of implementation and management of web portals, mobile applications, interactive dashboards, connected instrument utilization, RFID powered asset location, predictive maintenance, and data-driven prescriptive recommendations for use in connection with scientific, pharmaceutical, and medical research and diagnostic laboratories; remote technical and diagnostic support in the nature of monitoring technological functions to ensure optimal performance of laboratory instruments for scientific, medical, and pharmaceutical research and diagnostics use; remote technical and diagnostic support in the nature of monitoring technological functions to ensure optimal performance of computer hardware for scientific, research, medical, and diagnostics use; testing, inspection, evaluation, verification, analysis and development of laboratory equipment and protocols for compliance with regulatory, quality, quantity, consistency, performance, ethical or safety standards; benchmarking services for scientific, medical, and pharmaceutical research and diagnostic laboratories and equipment, namely, analyzing and providing strategic feedback regarding performance efficiency, usage and throughput, regulatory compliance, and quality standards of such laboratories and equipment; computational chemistry services for identification, design, optimization, and study of life sciences, namely biology, pharmacology, biomedical, and chemistry and pharmaceuticals; research in the fields of science, technology, medicine and health, namely, tissue culture maintenance and harvest, DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, and molecular compound characterization, for others for use in life science research and biotechnology research; consultation services in the field of science and technology, namely consultation in the field of cell and tissue culture maintenance and harvest, DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, molecular compound characterization, sample preparation and management, consumable laboratory product management, tracking usage, maintenance and management of assets and inventory, and scientific efficiencies and productivity, for use in life science research and biotechnology research; medical, research and laboratory diagnostic services in the field of DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, perform cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, and molecular compound characterization for others for use in life science research and biotechnology research; laboratory support services, namely, cell and tissue culture maintenance and harvest, preparation of cell and tissue media, DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, perform cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, molecular compound characterization, sample preparation and management, consumable laboratory product management, tracking usage, maintenance and management of assets and inventory, implementation of scientific efficiencies and productivity for others for use in life science research and biotechnology research, and daily equipment start-up and shut down; laboratory design; installation, maintenance, optimization, repair and refurbishment of computer software for scientific, medical, and pharmaceutical research, analysis, and diagnostics use


Classification kind code

11

Class [044]
Medical services in the nature of medical analysis for diagnosis and treatment purposes provided by medical laboratories; genetic analysis and reporting services for medical purposes; nucleic acid sequencing and analysis services for medical purposes; genome sequencing and analysis services for medical purposes; DNA screening for medical purposes; providing information in the field of DNA sequencing and genomics for medical purposes; consultation in the field of medicine, health and pharmaceuticals; DNA and polynucleic acid testing services for medical diagnostic services; conducting medical tests to diagnose disease


Classification kind code

11

Mark Details


Serial Number

1909962

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 09th Nov 2021
Agent Changed
Submitted for opposition 42
on 25th Aug 2021
Advertised
Submitted for opposition 27
on 28th Jul 2021
Approval Notice Sent
Submitted for opposition 26
on 28th Jul 2021
Approved
Submitted for opposition 22
on 14th Sep 2020
Search Recorded
Submitted for opposition 20
on 14th Sep 2020
Examiner's First Report
Submitted for opposition 48
on 29th Jul 2019
Agent Changed
Submitted for opposition 31
on 20th Jul 2018
Formalized
Submitted for opposition 1
on 18th Jul 2018
Created
Submitted for opposition 30
on 17th Jul 2018
Filed